Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2008-09-24 |
| Study Made Public: | 2011-08-08 |
Title
The effect of mixing novel HIV envelope antigens on the quality of neutralising antibody responses in rabbits.
Description
CAVD 319 is a preclinical rabbit study assessing 3 newly isolated HIV strains for immunizing potential, in comparison with CN54 gp140. None of the new strains proved as immunogenic as CN54.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.